Target intelligence / Profile preview

Ral guanine nucleotide dissociation stimulator (RALGDS)

Target
RALGDS
Molecular classification
Guanine nucleotide exchange factor (GEF), Enzyme (specifically, a GTPase regulator), Effector protein for Ras-related GTPases
01

Overview

Ral guanine nucleotide dissociation stimulator (RALGDS) is a ubiquitously expressed enzyme that functions as a guanine nucleotide exchange factor (GEF) for the small GTPases RalA and RalB, mediating the exchange of GDP for GTP to activate these proteins. RALGDS also serves as an effector for members of the Ras superfamily (including HRAS, KRAS, RRAS, and RAP1A), thus bridging Ras signaling to downstream cellular processes, notably in exocyst complex assembly and intracellular transport. It is critical in signal transduction pathways regulating cell growth, differentiation, and vesicle trafficking. Mutational studies have highlighted that specific residues within its Ras-interacting domain are essential for binding. Dysregulation of RALGDS or its signaling partners is implicated in cancer, underscoring its role as a therapeutic target. However, there are no known drugs directly targeting RALGDS as of the latest data.

Other names
RALGDSKIAA1308RGFRalGDSRalGEFRGDSRal guanine nucleotide exchange factor
02

Mechanism of action

Not applicable; there are currently no drugs directly targeting RALGDS described in the results.

03

Biological functions

Signal transductionRegulation of small GTPases (RalA, RalB)Intracellular transportAssembly of the exocyst complex in vesicle traffickingInteracts with Ras, Rap1A, Rap2A, HRAS, KRAS, RRAS, and others
04

Disease associations

Cancer (due to its link to Ras signaling and cell proliferation pathways)Autism spectrum disorder (association identified via genetic studies)Malignant otitis externa (association identified via genetic studies)

Beyond the preview

Go deeper on Ral guanine nucleotide dissociation stimulator (RALGDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ral guanine nucleotide dissociation stimulator (RALGDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call